VC-backed Relay Therapeutics goes public

Relay Therapeutics, a precision medicine company, has raised $400 million for its IPO after pricing its 20 million shares at $20 per share.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this